Skip to main content
Figure 3 | BMC Clinical Pharmacology

Figure 3

From: Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell®)

Figure 3

Nicotine plasma concentration after repeated intake of nicotine lozenges or gum (31 subjects). Nicotine plasma concentrations were determined from blood samples of 31 volunteers drawn before hourly administration of 1 or 2 mg nicotine lozenge or 4 mg nicotine gum (unconnected data points). Consecutive blood samples (connected data points) were drawn after administration of dose 12 (t = 11 h).

Back to article page

BMC Clinical Pharmacology

ISSN: 1472-6904